Pregnancy and autoimmune diseases

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 3, 2004, Pages 359-379

  Gordon, Caroline ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti phospholipid; Congenital heart block; Fetal loss; Lupus; Neonatal lupus syndrome; Pregnancy; Prematurity; SLE; Syndrome; Systemic sclerosis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; CLOMIFENE; CODEINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GOLD SALT; GONADORELIN; GONADOTROPIN; HEPARIN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; MORPHINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PETHIDINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID; TRAMADOL; UNINDEXED DRUG;

ADRENAL SUPPRESSION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BLEEDING; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL STUDY; CONGENITAL DISORDER; CONGENITAL HEART BLOCK; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG METABOLISM; DRUG TRANSPORT; DRUG USE; DUCTUS ARTERIOSUS OBLITERATION; FEMALE INFERTILITY; FETUS MORTALITY; FETUS WASTAGE; HUMAN; INFECTION; LABORATORY DIAGNOSIS; LUPUS ERYTHEMATOSUS; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL LITERATURE; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROLONGED PREGNANCY; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC DISEASE; RISK REDUCTION; SKIN BRUISING; SPONDYLOARTHROPATHY; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIA; THROMBOSIS; VASCULITIS;

AUTOIMMUNE DISEASES; BREAST FEEDING; DISEASE TRANSMISSION, VERTICAL; FEMALE; FERTILITY; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 3242671782     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.02.012     Document Type: Review

References (80)

1. Branch D.W. Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies Obstetrics and Gynecology 101 2003 1333-1344
2. Steen V.D. Medsger T.A. Jr. Fertility and pregnancy outcome in women with systemic sclerosis Arthritis and Rheumatism 42 1999 763-768
3. Khamashta M.A. Hughes G.R. Pregnancy in systemic lupus erythematosus Current Opinion in Rheumatology 8 1996 424-429
4. Petri M. Pregnancy in SLE Baillière's Clinical Rheumatology 12 1998 449-476
5. Guballa N. Sammaritano L. Schwartzman S. et al Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome Arthritis and Rheumatism 43 2000 550-556
6. Huong du L.T. Wechsler B. Vauthier-Brouzes D. et al Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles Seminars in Arthritis and Rheumatism 32 2002 174-188
7. Buyon J.P. Kalunian K.C. Ramsey-Goldman R. et al. Assessing disease activity in SLE patients during pregnancy Lupus 8 1999 677-684
8. Ruiz-Irastorza G. Lima F. Alves J. et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies British Journal of Rheumatology 35 1996 133-138
9. Khamashta M.A. Ruiz-Irastorza G. Hughes G.R. Systemic lupus erythematosus flares during pregnancy Rheumatic Disease Clinics of North America 23 1997 15-30
10. Urowitz M.B. Gladman D.D. Farewell V.T. Stewart J. McDonald J. Lupus and pregnancy studies Arthritis and Rheumatism 36 1993 1392-1397
11. Petri M. Pregnancy in SLE Baillière's Clinical Rheumatology 12 1998 449-476
12. Buyon J.P. Cronstein B.N. Morris M. Tanner M. Weissmann G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia American Journal of Medicine 81 1986 194-200
13. Ginsberg J.S. Thromboembolism and pregnancy Thrombosis and Haemostasis 82 1999 620-625
14. Durrani O.M. Gordon C. Murray P.I. Primary anti-phospholipid antibody syndrome (APS): current concepts Surveys in Ophthalmology 47 2002 215-238
15. Ginsberg J.S. Bates S.M. Management of venous thromboembolism during pregnancy Journal of Thrombosis and Haemostasis 1 2003 1435-1442
16. Lima F. Khamashta M.A. Buchanan N.M. et al A study of sixty pregnancies in patients with the antiphospholipid syndrome Clinical and Experimental Rheumatology 14 1996-131 136
17. Shehata H.A. Nelson-Piercy C. Khamashta M.A. Management of pregnancy in antiphospholipid syndrome Rheumatic Disease Clinics of North America 27 2001 643-659
18. Ornstein M.H. Rand J.H. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases Journal of Rheumatology 21 1994 1360-1364
19. Brennan P. Barrett J. Fiddler M. et al. Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy Journal of Rheumatology 27 2000 2843-2848
20. Ostensen M. Villiger P.M Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis Transplant Immunology 9 2002 155-160
21. Gran J.T. Ostensen M. Spondyloarthritides in females Baillière's Clinical Rheumatology 12 1998 695-715
22. Li D.K. Liu L. Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study British Medical Journal 327 2003 368-372
23. Ostensen M. Ostensen H. Ankylosing spondylitis-the female aspect Journal of Rheumatology 25 1998 120-124
24. Barrett J.H. Brennan P. Fiddler M. Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis Arthritis and Rheumatism 43 2000 1010-1015
25. Symmons D.P. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome Best Practice and Research Clinical Rheumatology 16 2002 707-722
26. Nelson J.L. Ostensen M. Pregnancy and rheumatoid arthritis Rheumatic Disease Clinics of North America 23 1997 195-212
27. Ramsey-Goldman R. The effect of pregnancy on the vasculitides Scandinavian Journal of Rheumatology Supplement 107 1998 116-117
28. Kumar A. Mohan A. Gupta R. et al. Relapse of Wegener's granulomatosis in the first trimester of pregnancy: a case report British Journal of Rheumatology 37 1998 331-333
29. Harber M.A. Tso A. Taheri S. Tuck S.M. Burns A. Wegener's granulomatosis in pregnancy-the therapeutic dilemma Nephrology Dialysis, Transplantation 14 1999 1789-1791
30. Auzary C. Huong D.T. Wechsler B. Vauthier-Brouzes D. Piette J.C. Pregnancy in patients with Wegener's granulomatosis: report of five cases in three women Annals of the Rheumatic Diseases 59 2000 800-804
31. Barry C. Davis S. Garrard P. Ferguson I.T. Churg-Strauss disease: deterioration in a twin pregnancy. Successful outcome following treatment with corticosteroids and cyclophosphamide British Journal of Obstetrics and Gynaecology 104 1997 746-747
32. Priori R. Tomassini M. Magrini L. et al. Churg-Strauss syndrome during pregnancy after steroid withdrawal Lancet 352 1998 1599-1600
33. Wechsler B. Genereau T. Biousse V. et al. Pregnancy complicated by cerebral venous thrombosis in Behcet's disease American Journal of Obstetrics and Gynecology 173 1995 1627-1629
34. Sharma B.K. Jain S. Vasishta K. Outcome of pregnancy in Takayasu arteritis International Journal of Cardiology 75 supplement 1 2000 S159-S162
35. Pisa F.E. Bovenzi M. Romeo L. et al Reproductive factors and the risk of scleroderma: an Italian case-control study Arthritis and Rheumatism 46 2002 451-456
36. Nelson J.L. Microchimerism in human health and disease Autoimmunity 36 2003 5-9
37. Artlett C.M. Microchimerism and scleroderma: an update Current Rheumatology Reports 5 2003 154-159
38. Steen V.D. Scleroderma and pregnancy Rheumatic Disease Clinics of North America 23 1997 133-147
39. Steen V.D. Pregnancy in women with systemic sclerosis Obstetrics and Gynecology 94 1999 15-20
40. Mok C.C. Kwan T.H. Chow L. Scleroderma renal crisis sine scleroderma during pregnancy Scandinavian Journal of Rheumatology 32 2003 55-57
41. Brown A.N. Bolster M.B. Scleroderma renal crisis in pregnancy associated with massive proteinuria Clinical and Experimental Rheumatology 21 2003 114-116
42. Tseng C.E. Buyon J.P. Neonatal lupus syndromes Rheumatic Disease Clinics of North America 23 1997 31-54
43. Morton M.R. Hypersensitivity vasculitis (microscopic polyangiitis) in pregnancy with transmission to the neonate British Journal of Obstetrics and Gynaecology 105 1998 928-930
44. Tseng C.E. Miranda E. Di Donato F. et al. mRNA and protein expression of SSA/Ro and SSB/La in human fetal cardiac myocytes cultured using a novel application of the Langendorff procedure Pediatric Research 45 1999 260-269
45. Buyon J.P. Clancy R.M. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus Autoimmunity 36 2003 41-50
46. Buyon J.P. Neonatal lupus Current Opinion in Rheumatology 8 1996 485-490
47. Askanase A.D. Friedman D.M. Copel J. et al Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies Lupus 11 2002 145-151
48. Petri M. Systemic lupus erythematosus and pregnancy Rheumatic Disease Clinics of North America 20 1994 87-118
49. Kaplan D. Fetal wastage in patients with rheumatoid arthritis Journal of Rheumatology 13 1986 875-877
50. Black C.M. Stevens W.M. Scleroderma. Rheumatic Disease Clinics of North America 15 1989 193-212
51. Silman A.J. Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study Annals of the Rheumatic Diseases 47 1988 441-444
52. Scarpinato L. Mackenzie A.H. Pregnancy and progressive systemic sclerosis. Case report and review of the literature Cleveland Clinical Quarterly 52 1985 207-211
53. Buchanan N.M. Toubi E. Khamashta M.A. Lima F. Kerslake S. Hughes G.R. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases Annals of the Rheumatic Diseases 55 1996 486-488
54. Parke A. West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus Journal of Rheumatology 23 1996 1715-1718
55. Levy R.A. Vilela V.S. Cataldo M.J. et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study Lupus 10 2001 401-404
56. Ostensen M. Hartmann H. Salvesen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature Journal of Rheumatology 27 2000 1872-1875
57. Chakravarty E.F. Sanchez-Yamamoto D. Bush T.M. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes Journal of Rheumatology 30 2003 241-246
58. Luisiri P. Lance N.J. Curran J.J. Wegener's granulomatosis in pregnancy Arthritis and Rheumatism 40 1997 1354-1360
59. Dayoan E.S. Dimen L.L. Boylen C.T. Successful treatment of Wegener's granulomatosis during pregnancy: a case report and review of the medical literature Chest 113 1998 836-838
60. Huong D.L. Amoura Z. Duhaut P. et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients Journal of Rheumatology 29 2002 2571-2576
61. Nowack R. Gobel U. Klooker P. Hergesell O. Andrassy K. van der Woude F.J. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement Journal of the American Society of Nephrology 10 1999 1965-1971
62. Daina E. Schieppati A. Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases Annals of Internal Medicine 130 1999 422-426
63. Chan T.M. Li F.K. Tang C.S. et al Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group New England Journal of Medicine 343 2000 1156-1162
64. Cross J. Jayne D. Mycophenolate mofetil in lupus nephritis Lupus 9 2000 647-650
65. Empson M. Lassere M. Craig J.C. Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials Obstetrics and Gynecology 99 2002 135-144
66. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone American Journal of Obstetrics and Gynecology 174 1996 1584-1589
67. Rai R. Cohen H. Dave M. Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) British Medical Journal 314 1997 253-257
68. Farquharson R.G. Quenby S. Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstetrics and Gynecology 100 2002 408-413
69. Rai R. Regan L. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstetrics and Gynecology 100 2002 1354-356
70. Kutteh W.H. Antiphospholipid syndrome in pregnancy Obstetrics and Gynecology 100 2002 1354-1356
71. Ruiz-Irastorza G. Khamashta M.A. Hughes G.R. Heparin and osteoporosis during pregnancy: 2002 update Lupus 11 2002 680-682
72. Cowchock F.S. Reece E.A. Balaban D. et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment American Journal of Obstetrics and Gynecology 166 1992 1318-1323
73. Silver R.K. MacGregor S.N. Sholl J.S. et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients American Journal of Obstetrics and Gynecology 169 1993 1411-1417
74. Gordon C. Kilby M.D. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome Lupus 7 1998 429-433
75. Clark A.L. Branch D.W. Silver R.M. et al. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy Obstetrics and Gynecology 93 1999 437-441
76. Branch D.W. Peaceman A.M. Druzin M. et al multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group American Journal of Obstetrics and Gynecology 182 1 part 1 2000 122-127
77. Somerset D.A. Raine-Fenning N. Gordon C. et al. Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus European Journal of Obstetrics, Gynecology and Reproductive Biology 79 1998 227-229
78. Tincani A. Branch W. Levy R.A. et al Treatment of pregnant patients with antiphospholipid syndrome Lupus 12 2003 524-529
79. Dekker G. Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia Lancet 357 2001 209-215
80. Lowe S.A. Drugs in pregnancy. Anticonvulsants and drugs for neurological disease Best Practice and Research Clinical Obstetrics and Gynaecology 15 2001 863-876